Glaxo, SmithKline are likely to keep a tight lid on details of merger plan

Article Abstract:

Glaxo Wellcome PLC and SmithKline Beecham PLC are not expected to reveal details about their planned 46 billion pounds (76.63 billion euros) merger. The silence on the merger reflects the efforts by both companies to improve their leverage with antitrust regulators.

---

Glaxo, SmithKline push back merger date by one month

Article Abstract:

The proposed 46 billion pounds (74.57 billion euros) merger between SmithKline Beecham PLC and Glaxo Wellcome PLC has been postponed by one month due to a antitrust review in the US. The merger is now expected to be completed on September 25, 2000.

---

Glaxo-SmithKline merger hits new regulatory snag, hurting shares

Article Abstract:

Shares of Glaxo Wellcome PLC and SmithKline Beecham PLC dropped on Monday after the UK pharmaceutical firms encountered new regulatory delays in their proposed GBP48.8 billion (Euro79.78 billion) merger.

Asset sales & divestitures

Similar abstracts:

• Abstracts: Audit links Suharto family to corruption at power plant. (Indonesia). Wahid Takes Hard Line With Foreign-Owned Indorayon
• Abstracts: Submarine launch heralds the next generation of German Navy boats. First-of-class German F 124 anti-air warfare frigate named
• Abstracts: EBay is in talks to buy iBazar for about 100 million euros in stock. Cap Gemini Group to bid 11.5 billion euros for consulting firm
• Abstracts: Newmont Gold -mine closure blocked by Supreme Court. (Indonesia's Supreme Court). Geologist doubt fraud in Bre-X's Busang find
• Abstracts: Radiotronica Is Digging Its Way Into The Telecommunications World. Telefonos de Mexico plans to list on Latibex

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.